| Literature DB >> 22030398 |
Shinrye Lee1, Jong-Heon Kim1, Jae-Hong Kim1, Jung-Wan Seo1, Hyung-Soo Han2, Won-Ha Lee3, Kiyoshi Mori4, Kazuwa Nakao4, Jonathan Barasch5, Kyoungho Suk6.
Abstract
The secreted protein lipocalin-2 (LCN2) has been implicated in diverse cellular processes, including cell morphology and migration. Little is known, however, about the role of LCN2 in the CNS. Here, we show that LCN2 promotes cell migration through up-regulation of chemokines in brain. Studies using cultured glial cells, microvascular endothelial cells, and neuronal cells suggest that LCN2 may act as a chemokine inducer on the multiple cell types in the CNS. In particular, up-regulation of CXCL10 by JAK2/STAT3 and IKK/NF-κB pathways in astrocytes played a pivotal role in LCN2-induced cell migration. The cell migration-promoting activity of LCN2 in the CNS was verified in vivo using mouse models. The expression of LCN2 was notably increased in brain following LPS injection or focal injury. Mice lacking LCN2 showed the impaired migration of astrocytes to injury sites with a reduced CXCL10 expression in the neuroinflammation or injury models. Thus, the LCN2 proteins, secreted under inflammatory conditions, may amplify neuroinflammation by inducing CNS cells to secrete chemokines such as CXCL10, which recruit additional inflammatory cells.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22030398 PMCID: PMC3243551 DOI: 10.1074/jbc.M111.299248
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157